Advances in Myositis
Myositis is inflammation or swelling of the muscles. Injury, medicines, infection, or an immune disorder can lead to myositis. It is a documented side effect of the lipid-lowering drugs statins and fibrates.
Sample Chapter(s)
Preface (46 KB)
Components of the Book:
  • Chapter1
    Patient-centred standards of care for adults with myositis
  • Chapter2
    Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis
  • Chapter3
    Infective myositis
  • Chapter4
    Muscle Weakness in Myositis: MicroRNA‐Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies
  • Chapter5
    The EuroMyositis registry: an international collaborative tool to facilitate myositis research
  • Chapter6
    Update on Malignancy in Myositis—Well-Established Association with Unmet Needs
  • Chapter7
    Gene fitness landscape of group A streptococcus during necrotizing myositis
  • Chapter8
    Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
  • Chapter9
    Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
  • Chapter10
    Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis
  • Chapter11
    Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies are Associated with DRB1*07:01 and Severe Myositis in Pediatric Myositis Patients
  • Chapter12
    Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
  • Chapter13
    Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review
  • Chapter14
    Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity
  • Chapter15
    New Pathogenesis Mechanisms and Translational Leads Identified by Multidimensional Analysis of Necrotizing Myositis in Primates
Readership: Students, academics, teachers and other people attending or interested in Myositis
James B. Lilleker
Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Stott Lane, Salford, UK

Patrick Gordon
King’s College Hospital NHS Foundation Trust, London, UK

Janine A. Lamb
Centre for Integrated Genomic Medical Research, School of Health Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK

Heidi Lempp
Academic Rheumatology, Faculty of Life Sciences & Medicine, King’s College London, London, UK

Paula Jordan
Myositis UK, Southampton, UK

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top